FINANCIALS

TGTX Tg Therapeutics Inc 1001316

Income Statement
Revenue	tgtx20240930_10q	83,879,000
Net Income	tgtx20240930_10q	3,880,000
Profit Margin		4.63%

Balance Sheet
Current Assets	574,069,000
Assets	586,014,000
Current Liabilities	125,114,000
Liabilities	393,857,000
Equity	192,157,000
Shares Out	154,823,000

Cash Flow Statement
Operating Cash Flow	-14,876,000
Investing Cash Flow	-16,824,000

Market Analysis
Market Cap	3,954,182,115
Price	29.55
BVPS	1.24
PB	23.81
EPS	0.60
PE	42.51
PS	11.79
FCF	-31,700,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TGTX documents filed with the SEC.

TGTX Filings Clear

View A List of Tickers